Target intelligence / Profile preview

Erythrocyte membrane-cytoskeleton complex

Molecular classification
Cytoskeletal protein, Membrane protein, Structural protein
01

Overview

The erythrocyte membrane-cytoskeleton complex is a specialized structural network that determines the shape, stability, and deformability of red blood cells (RBCs). It consists of a lipid bilayer anchored to a two-dimensional protein meshwork primarily composed of spectrin, actin, ankyrin, and protein 4.1, which interact with integral membrane proteins like Band 3 and glycophorins (Mohandas & Gallagher, 2008). This organization allows the RBC to withstand high shear stress and undergo the extreme deformations required to navigate narrow capillaries and splenic slits (Da Costa et al., 2013). In diseases such as sickle cell anemia, malaria, and diabetes, the membrane becomes rigid due to oxidative damage, protein cross-linking, or pathological hemoglobin interactions, leading to impaired microcirculation and hemolysis (Vichinsky et al., 2019). Pharmacological agents like pentoxifylline and voxelotor target these components or their environment to improve rheological properties, reduce blood viscosity, and enhance oxygen delivery to tissues (Diederich et al., 2018).

Other names
Erythrocyte membraneRBC cytoskeletonRed cell membrane proteinsErythrocyte skeleton
02

Mechanism of action

Increasing intracellular ATP levels to maintain active transport, reducing oxidative stress on structural proteins, inhibiting pathological hemoglobin polymerization, and modulating lipid bilayer fluidity.

03

Biological functions

Cellular mechanicsMembrane stabilityRheological regulationGas exchange support
04

Disease associations

Sickle cell diseaseHereditary spherocytosisDiabetes mellitusPeripheral vascular diseaseMalaria
05

Safety considerations

Risk of induced hemolysis if membrane integrity is compromisedPotential off-target effects on non-erythroid cytoskeletal structuresLimited therapeutic window for rheological agents
06

Interacting drugs

Pentoxifylline

4 more in the full profile.

07

Biomarkers

Elongation index (ektacytometry)RBC filtration rateHemoglobin S percentageHemolysis markers (LDH, bilirubin)

Beyond the preview

Go deeper on Erythrocyte membrane-cytoskeleton complex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Erythrocyte membrane-cytoskeleton complex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call